Cargando…

Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells

Antisense gapmer oligonucleotides containing phosphoryl guanidine (PG) groups, e.g., 1,3-dimethylimidazolidin-2-imine, at three to five internucleotidic positions adjacent to the 3′ and 5′ ends were prepared via the Staudinger chemistry, which is compatible with conditions of standard automated soli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kupryushkin, Maxim S., Filatov, Anton V., Mironova, Nadezhda L., Patutina, Olga A., Chernikov, Ivan V., Chernolovskaya, Elena L., Zenkova, Marina A., Pyshnyi, Dmitrii V., Stetsenko, Dmitry A., Altman, Sidney, Vlassov, Valentin V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693280/ https://www.ncbi.nlm.nih.gov/pubmed/34976439 http://dx.doi.org/10.1016/j.omtn.2021.11.025

Ejemplares similares

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
por: Markov, Oleg V., et al.
Publicado: (2020)

Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties
por: Miroshnichenko, S. K., et al.
Publicado: (2019)

Phosphoryl Guanidines: A New Type of Nucleic Acid Analogues
por: Kupryushkin, M. S., et al.
Publicado: (2014)

Data for isolation and properties analysis of diastereomers of a mono-substituted phosphoryl guanidine trideoxyribonucleotide
por: Lomzov, Alexander A., et al.
Publicado: (2019)

Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H
por: Patutina, O. A., et al.
Publicado: (2018)

Effects of combinations of gapmer antisense oligonucleotides on the target reduction
por: Yanagidaira, Mitsugu, et al.
Publicado: (2023)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy
por: Patutina, Olga A, et al.
Publicado: (2010)

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma
por: Sen'kova, Alexandra V., et al.
Publicado: (2012)

Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene
por: Chernikov, Ivan V., et al.
Publicado: (2017)

Data on multimerization efficiency for short linear DNA templates and phosphoryl guanidine primers during isothermal amplification with Bst exo- DNA polymerase
por: Garafutdinov, Ravil R., et al.
Publicado: (2020)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides
por: Yoshida, Tokuyuki, et al.
Publicado: (2022)

Evaluation of off‐target effects of gapmer antisense oligonucleotides using human cells
por: Yoshida, Tokuyuki, et al.
Publicado: (2019)

Fluorescent base analogues in gapmers enable stealth labeling of antisense oligonucleotide therapeutics
por: Nilsson, Jesper R., et al.
Publicado: (2021)

New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids
por: Patutina, O.A., et al.
Publicado: (2009)

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
por: Castanotto, Daniela, et al.
Publicado: (2015)

Folate-Equipped Cationic Liposomes Deliver Anti-MDR1-siRNA to the Tumor and Increase the Efficiency of Chemotherapy
por: Gladkikh, Daniil V., et al.
Publicado: (2021)

An Influence of Modification with Phosphoryl Guanidine Combined with a 2′-O-Methyl or 2′-Fluoro Group on the Small-Interfering-RNA Effect
por: Pavlova, Anna S., et al.
Publicado: (2021)

Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy
por: Watt, Andrew T., et al.
Publicado: (2020)

MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2013)

The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2017)

Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals
por: Seth, Punit P, et al.
Publicado: (2012)

Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile
por: Hegarty, John P, et al.
Publicado: (2016)

Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
por: Østergaard, Michael E, et al.
Publicado: (2020)

Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus
por: Okamoto, Shunsuke, et al.
Publicado: (2023)

Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides
por: Kasuya, Takeshi, et al.
Publicado: (2016)

A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer
por: Shimojo, Masahito, et al.
Publicado: (2019)

Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts
por: Shin, Minwook, et al.
Publicado: (2022)

Amphiphilic “Like-A-Brush” Oligonucleotide Conjugates with Three Dodecyl Chains: Self-Assembly Features of Novel Scaffold Compounds for Nucleic Acids Delivery
por: Pavlova, Anna S., et al.
Publicado: (2020)

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance
por: Patutina, Olga, et al.
Publicado: (2020)

Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022)

RNase T1 mimicking artificial ribonuclease
por: Mironova, N. L., et al.
Publicado: (2007)

Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy
por: Gaponova, Svetlana, et al.
Publicado: (2022)

Current Development of siRNA Bioconjugates: From Research to the Clinic
por: Chernikov, Ivan V., et al.
Publicado: (2019)

Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model
por: Patutina, Olga A., et al.
Publicado: (2019)

A New Antisense Phosphoryl Guanidine Oligo-2′-O-Methylribonucleotide Penetrates Into Intracellular Mycobacteria and Suppresses Target Gene Expression
por: Skvortsova, Yulia V., et al.
Publicado: (2019)

Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group
por: Petrova, Natalya S., et al.
Publicado: (2012)

Allele-Specific PCR for KRAS Mutation Detection Using Phosphoryl Guanidine Modified Primers
por: Chubarov, Alexey S., et al.
Publicado: (2020)

Novel Peptide Conjugates of Modified Oligonucleotides for Inhibition of Bacterial RNase P
por: Novopashina, Darya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_remqj3he7nap98jvfc5tgdnnp1